New York Rep. Chris Collins surged into the national consciousness on Wednesday, when he was indicted on charges of insider trading in relation to a company named Innate Immunotherapeutics Limited, a company in which he is the largest shareholder and, until relatively recently, served on its board. Collins denies the charges but, in the immediate aftermath of the indictment, he was removed from the House Energy and Commerce Committee by Speaker Paul Ryan.